Impact Biomedical Initiates Quantum, a New Frontier in Pharmaceutical Development
SINGAPORE, July 31, 2020 – (ACN Newswire) – Impact Biomedical, a wholly-owned subsidiary of SGX-listed Singapore eDevelopment, has announced the
Read MoreSINGAPORE, July 31, 2020 – (ACN Newswire) – Impact Biomedical, a wholly-owned subsidiary of SGX-listed Singapore eDevelopment, has announced the
Read More